EUVIMEDEUVIMED entdecken
Open Access

Mitochondrial complex IV remodeling in tumor-associated macrophages amplifies interferon signaling and promotes anti-tumor immunity

Megan L Clark, Kamen P Simeonov, Walter K Mowel, Michaël F Michieletto, Leonel Joannas, Jasmine M Wright, Isabel Erickson, Lexus R Johnson, Rakesh Krishnan, César de la Fuente-Núñez, Andy J Minn, Jorge Henao-Mejia

Immunity · 2025-07 · 58 (7) · 1670-1687.e12

DOI: 10.1016/j.immuni.2025.06.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2025-07. Verfasst von Megan L Clark und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for …. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Interferons, Mitochondria, Melanoma, Experimental. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) influence tumor progression and immune checkpoint blockade (ICB) efficacy. Interferon (IFN)-TAMs predict better survival and ICB responses, yet the mechanisms governing IFN-TAMs remain unclear. Here, we identify NDUFA4, a complex IV subunit of the electron transport chain, as a functional switch controlling TAM function and anti-tumor immunity. NDUFA4 expression sustained pro-tumoral TAMs. However, intratumoral IFNs decreased NDUFA4 expression in TAMs via the cooperative action of NDUFA4L3 and miR-147, co-encoded by a conserved bifunctional transcript. Mechanistically, NDUFA4 repression increased mitochondrial DNA release into the cytoplasm and subsequent STING activation, thereby amplifying anti-tumor IFN-induced transcriptional programs in TAMs. Finally, we designed RNA-based therapeutics that leveraged the specificity of miR-147 for the Ndufa4 transcript to enhance ICB efficacy and inhibit B16 melanoma tumor growth. These findings uncover mitochondrial complex IV remodeling as a critical mechanism governing the functional adaptation of macrophages to distinct microenvironments with broad implications for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor-Associated MacrophagesInterferonsMitochondriaMelanoma, ExperimentalAnimalsMiceSignal TransductionMicroRNAsMice, Inbred C57BLHumansTumor MicroenvironmentCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

STINGcGAScomplex IVelectron transport chainimmune checkpoint blockadeinterferon-stimulated genesmitochondriatumor immunitytumor microenvironmenttumor-associated macrophages

Substanzen

MicroRNAsInterferons

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology and Immune Health (I3H), Perelman School of Medicine, Unive…
  • Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Center for Metastasis Research eXcellence (MET-X), Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Penn Department o…
  • Institute for Immunology and Immune Health (I3H), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsy…
  • Machine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Ph…

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • Chan Zuckerberg Initiative
  • Pew Charitable Trusts
  • Israel National Road Safety Authority

Zitieren

APA

Clark, M. L., Simeonov, K. P., Mowel, W. K., Michieletto, M. F., Joannas, L., Wright, J. M., Erickson, I., Johnson, L. R., Krishnan, R., de la Fuente-Núñez, C., Minn, A. J., & Henao-Mejia, J. (2025). Mitochondrial complex IV remodeling in tumor-associated macrophages amplifies interferon signaling and promotes anti-tumor immunity. Immunity, 58(7), 1670-1687.e12. https://doi.org/10.1016/j.immuni.2025.06.006

Vancouver

Clark ML, Simeonov KP, Mowel WK, Michieletto MF, Joannas L, Wright JM, et al. Mitochondrial complex IV remodeling in tumor-associated macrophages amplifies interferon signaling and promotes anti-tumor immunity. Immunity. 2025;58(7):1670-1687.e12. doi:10.1016/j.immuni.2025.06.006

BibTeX
@article{Clark2025,
  author = {Clark, Megan L and Simeonov, Kamen P and Mowel, Walter K and Michieletto, Michaël F and Joannas, Leonel and Wright, Jasmine M and Erickson, Isabel and Johnson, Lexus R and Krishnan, Rakesh and de la Fuente-Núñez, César and Minn, Andy J and Henao-Mejia, Jorge},
  title = {Mitochondrial complex IV remodeling in tumor-associated macrophages amplifies interferon signaling and promotes anti-tumor immunity},
  journal = {Immunity},
  year = {2025},
  volume = {58},
  number = {7},
  pages = {1670--1687.e12},
  doi = {10.1016/j.immuni.2025.06.006}
}
Kostenlos starten →